WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO) reported that its President and Chief Executive Officer, Shai N. Gozani , M.D., Ph.D., provided an update and overview of company business activities on January 14, 2015 at the Biotech Showcase 2015 conference in San Francisco . Dr.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported strong interest in Quell coming out of last week's Consumer Electronics Show (CES). According to Frank McGillin , SVP and General Manager of Consumer Health at NeuroMetrix , "In the first several days that the
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that Quell has been featured in several forums during this year's International Consumer Electronics Show (CES). Among the highlights: NeuroMetrix President and Chief Executive Officer, Shai N.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that industry insiders got their first look at Quell during day 1 of this year's International Consumer Electronics Show (CES). Quell utilizes NeuroMetrix's proprietary non-invasive neurostimulation technology to
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. announced today that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2015 Conference being held in San Francisco, CA. Dr. Gozani intends to provide an overall business update and a
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) will unveil and demonstrate Quell, a novel wearable pain relief device at the 2015 International Consumer Electronics show (CES) January 6-9 in Las Vegas . Attendees will get their first glimpse of Quell at Booth # 73311 in the
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will join an exclusive number of companies to participate in CES Unveiled, the official press event of the International Consumer Electronics Show in Las Vegas in January 2015 .
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported today that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent application covering unique aspects of the Company's wearable pain relief technology.
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today announced that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, will be participating in the one-on-one Benchmark Micro Cap Discovery Conference which will be held at the Palmer House Hilton , Chicago, IL
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it will unveil Quell™, the Company's wearable pain relief device at the International Consumer Electronics Show (CES) in Las Vegas in January 2015 . Quell™ Wearable Pain Relief Device (Photo: Business Wire)
